Cargando...
ASCO 2018: highlights of urothelial cancer and prostate cancer
Prostate cancer and urothelial carcinoma are the two most common urological cancers. The aim of this short review is to highlight abstracts from this year’s ASCO Annual Meeting. The phase III SPCG-13 trial showed no difference in biochemical disease-free survival by the addition of docetaxel after p...
Guardado en:
| Publicado en: | Memo |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Vienna
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280775/ https://ncbi.nlm.nih.gov/pubmed/30595755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-018-0422-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|